General Information of the Compound
Compound ID
CP0220677
Compound Name
N-(3,4-dihydro-2H-chromen-3-ylmethyl)-N'-(1,4,5,6-tetrahydropyrimidin-2-yl)propane-1,3-diamine
    Show/Hide
Structure
Formula
C17H26N4O
Molecular Weight
302.422
Canonical SMILES
C(CNCC1COc2ccccc2C1)CNC1=NCCCN1
    Show/Hide
InChI
InChI=1S/C17H26N4O/c1-2-6-16-15(5-1)11-14(13-22-16)12-18-7-3-8-19-17-20-9-4-10-21-17/h1-2,5-6,14,18H,3-4,7-13H2,(H2,19,20,21)
    Show/Hide
InChIKey
MFIBUSVOFFHBJJ-UHFFFAOYSA-N
Physicochemical Property
logP
1.1563
Rotatable Bonds
6
Heavy Atom Count
22
Polar Areas
57.68
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44322952
ChEMBL ID
CHEMBL88661
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000803 HA7 Homo sapiens (Human)  1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS